Skip to main content
. 2023 Dec 21;29(1):67. doi: 10.3390/molecules29010067

Figure 2.

Figure 2

The structure–inhibition relationship for anticancer activity of 1-(1,3-dioxoisoindolin-2-yl)-3-aryl urea analogs.